EBS vs TRMB · rev $1.04B vs P/E 26, rev $3.68B
Emergent Biosolutions Inc (EBS) versus Trimble Inc (TRMB) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Trimble Inc (TRMB) is a scientific & technical instruments company listed on NASDAQ.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported TRMB revenue for 2025-01-03 was $3.68B. Net income was $1.50B. Revenue was down 3.0% from 2023-12-29 to 2025-01-03. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
EBS currently screens at market cap $416.4M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
Not investment advice. Open the EBS and TRMB stock pages for the full models.
Not investment advice.